It is well known that all tumors contain a certain percentage of hypoxic cells that resist the effects of irradiation.
2-Nitroimidazole derivatives gained much attention. Misonidazole (MISO) is being used in a phase III clinical trial. 4) Its major biological effects are radiosensitization of hypoxic tumor cells, 5) direct killing of hypoxic tumor cells, 6) undesirable radiosensitization of certain normal tissues, 7) and neurotoxicity. 8) Much effort has been devoted to developing effective nitroheterocyclic compounds by the introduction of additional biologically active functional groups. Nagasawa et al., 9) Hori et al., 10) and Kasai et al. 11, 12) have developed several new 2-nitroimidazole hypoxic cell radiosensitizers that were designed to enhance their sensitizing ability by substituting their aromatic rings with some biologically active and chemically reactive groups such as hydroxamic acid and oxime with moderate lipophilicity. Among these hypoxic cell radiosensitizers, KIN-804 and its homologous analogue KIN-844, and the immunopotentiating hypoxic cell radiosensitizers, KIN-806 and its analogue TX-1877, were selected to be examined in the present study. The enhancement ratios (at 1 mM) of KIN-804, KIN-844, KIN-806, and TX-1877 were reported to be 2.00, 1.69, 1.91, and 1.75, respectively. KIN-804 was reported to regress tumor size when followed by radiation exposure. 13) In correlation, its biochemical changes were published previously. 14, 15) KIN-806 also exhibited bifunctional radiosensitizing activity and suppression of lung metastasis. Similarly, TX-1877 is a novel type of bifunctional antimetastatic and immunopotentiating radiosensitizer.
To understand the biological features of the 2-nitroimidazole derivatives, the present study examined the effects of KIN-804, KIN-844, KIN-806, and TX-1877 on brain acetylcholinesterase (AChE) levels as an indicator of neurotoxicity, in comparison with MISO as a positive control, liver antioxidant enzymes, such as superoxide dismutase (SOD) and catalase, and liver free radical scavenging systems, such as glutathione (GSH) content and glucose-6-phosphate dehydrogenase (G-6-PDH) levels, in tumor-bearing mice with and without subsequent irradiation exposure.
MATERIALS AND METHODS

Animals
Female Swiss albino mice weighing 18-20 g obtained from the breeding unit of the National Cancer Institute, Cairo University (Cairo, Egypt), were used throughout this study. The animals were maintained on a standard cube diet and water ad libitum.
Tumor Ehrlich ascites carcinoma (EAC) 2.5ϫ10 6 cells was transplanted subcutaneously into the back of the female Swiss albino mice, and these mice were used throughout this study. The EAC transplantation killed the mice in about 20 d.
Drugs MISO was generously supplied by Professor H.K. Awwad, National Cancer Institute, Cairo University. KIN-804, KIN-844, KIN-806, and TX-1877 were synthesized in our laboratory as reported previously. [9] [10] [11] [12] The chemical structures of drugs used are shown in Fig. 1 . Also, based on the results of a preliminary study, all parameters reported here were detected using each drug at concentrations ranging from 10-200 mg/kg body weight. The maximum effect was found at the dose of 50 mg/kg body weight for almost all parameters examined and then reached a plateau. This dose is less than 10% of the detected LD 50 of each drug. Accordingly, it was selected as the optimal dose.
Each drug alone was emulsified in a few drops of Tween-80 and then diluted to the appropriate concentration with sterilized bi-distilled water. Each mice received a dose equivalent to 50 mg/kg body weight i.p. (the optimal dose). The control group received the same amount of Tween-80 in sterilized bi-distilled water. All other chemicals were of the highest purity available.
Irradiation A Philips SL 75.0 photon irradiator was used to deliver 10 Gy (whole-body irradiation) at a dose rate of 0.1032 C/kg/min.
Groups under Investigation The groups of animals were designated as control (G1), EAC-bearing mice (G2), EAC-bearing mice (14 d) subjected to irradiation (G3), EACbearing mice (14 d) treated with each drug alone (G4), and EAC-bearing mice (14 d) subjected to irradiation 20 min after receiving each drug examined alone (G5).
Biochemical Analyses The animals were killed 15 d from the inoculation of EAC cells. The animals were then dissected, total brain tissues were collected for AChE determination, and liver tissues were removed after perfusion with ice-cold 0.9% sodium chloride for the detection of antioxidant enzyme systems and free radical scavenging systems. Ten percent homogenate was prepared in an ice-cold phosphate buffer (50 mM, pH 7.8) using a Potter Elvehjem homogenizer.
Brain AChE Activity The entire brain was excised with minimum of direct handling, then wiped dry with filter paper. AChE activity was detected by the method reported by Ellman et al. 16) The method is based on measurement of the rate of production of thiocholine, as the substrate acetylthiocholine is hydrolyzed by brain AChE. The liberated thiol reacts with the dithiobisnitrobenzoate ion to yield 5-thio-2-nitrobenzoic acid with a specific yellow color detected spectrophotometrically.
SOD and Catalase Activities The assay of SOD activity was carried out according to the method of Minami and Yoshikawa 17) based on the generation of superoxide anions by pyrogallol autoxidation, detection of superoxide anions by nitroblue tetrazolium formazan color development, and by measuring the amount of superoxide anions generated and scavenged by SOD (the inhibitory level of formazan color development).
The assay of catalase activity was done according to the method of Johansson and Borg 18) based on the catalytic peroxidation function of the enzyme. Methanol was used as the hydrogen donor, and the production of formaldehyde was measured spectrophotometrically with purpald (4-amino-3-hydrazino-5-mercapto-1,2,4-triazole) as a chromogen.
GSH and G-6-PDH Levels GSH content was detected as described by Beutler et al. 19) based upon the determination of a yellow color that develops when 5,5-dithiol-bis(2-nitrobenzoic acid) is added to sulfhydryl compounds. G-6-PDH levles were estimated according to the method of Kornberg and Horecker 20) by reacting G-6-P with NADP in the presence of G-6-PDH to produce NADPH, and gluconate-6-phosphate, and H ϩ .
RESULTS
Brain AChE Levels
The effects of KIN-804, KIN-844, KIN-806, and TX-1877 in comparison with MISO on brain AChE activity are shown in Table 1 . In the control brain tissues, the mean value of AChE activity was 3.89Ϯ0.31ϫ10 6 mol/min/g wet tissue. Twenty-four hours after the administration of MISO at the optimal dose of 50 mg/kg body weight, a slight but significant decrease in AChE activity to 3.21Ϯ 0.33ϫ10 6 mol/min/g wet tissue with 17.5% (pϽ0.005) inhibition was observed. In comparison, the administration of KIN-804, KIN-844, KIN-806, and TX-1877 at their optimal doses of 50 mg/kg body weight expressed AChE activities (as 10 6 mol/min/g wet tissues) of 3.89Ϯ0.34, 3.91Ϯ0.21, 3.85Ϯ 0.29, and 3.88Ϯ0.25, respectively.
Free Radical Scavenging Activities in EAC-bearing Mice. GSH Content As shown in Table 2 , the GSH content in liver tissues of the control (G1) was 2.41Ϯ0.13 mg/g wet tissue. Inoculation of EAC (G2) significantly decreased the GSH content to 1.64Ϯ0.10 mg/g wet tissue, representing 32.0% (pϽ0.001) inhibition compared with controls (G1). When the EAC-bearing mice received 10 Gy (G3), the GSH content slightly recovered to 1.89Ϯ0.12 mg/g wet tissue of a G-6-PDH Activity Table 3 illustrates G-6-PDH activity. The G1 control group had G-6-PDH levels of 36.8Ϯ1.7 U/g wet tissue, which was significantly decreased in the EACbearing mice (G2) to 16.5Ϯ1.1 U/g wet tissue [55.2% (pϽ0.001) inhibition]. Treatment of the EAC-bearing mice with a single dose of 10-Gy gamma-irradiation (G3) slightly reduced the effect of bearing EAC with G-6-PDH levels of 20.4Ϯ1.2 U/g wet tissue: 23.6% (pϽ0.005) increase with respect to G2 and 44.6% (pϽ0.001) decrease with respect to G1. After single-dose administration of KIN-804, KIN-844, KIN-806, and TX-1877 50 mg/kg body weight to EAC-bearing mice (G4) G-6-PDH levels were 16.1Ϯ1.9, 16.4Ϯ1.2, 16.8Ϯ1.1 and 16.9Ϯ1.4 U/g wet tissue, respectively. In comparison with G1, the G4 group had approximately the same percentages as G2 at 56.2% (pϽ0.001), 55.4% (pϽ0.001), 54.3% (pϽ0.001), and 54.1% (pϽ0.001) for KIN-804, KIN-844, KIN-806, and TX-1877, respectively. There was no significant difference between G4 and G2 (Table 3) . On the other hand, the combined treatment of KIN-804, KIN-844, KIN-806, and TX-1877 50 mg/kg body weight with gammairradiation (G5) resulted in G-6-PDH levels of 20.6Ϯ1.4, 19.8Ϯ1.1, 21.1Ϯ1.8, and 25.1Ϯ1.1 U/g wet tissue, respectively. These results in the G5 group slightly reversed the effect of EAC inoculation (G2) by 24.8% (pϽ0.005), 20.0% (pϽ0.005), 27.9% (pϽ0.005), and 52.1% (pϽ0.001), respectively.
Antioxidant Enzymes in EAC-bearing Mice. SOD Activity As shown in Table 4 , SOD level in the liver of EACbearing mice (G2) was significantly decreased to 326.5Ϯ 11.4 mg/g wet tissue in comparison with the control (G1) 495.8Ϯ25.7 mg/g wet tissue [34.1% (pϽ0.001)]. After a single dose of gamma-irradiation, the SOD level in the G3 group was 381.1Ϯ16.6 mg/g wet tissue, a slight increase (16.7%, pϽ0.01) in comparison with EAC-bearing mice (G2) and decreased more (23.1%, pϽ0.001) with respect to G1. After the single-dose administration of KIN-804, KIN- 844, KIN-806, and TX-1877 50 mg/kg body weight in the G4 group the SOD level was 369.5Ϯ21.9, 380.2Ϯ17.4, 405.9Ϯ 22.5 and 419.1Ϯ11.9 mg/g wet tissue, respectively. These results were 25.5% (pϽ0.001), 23.3% (pϽ0.001), 18.1% (pϽ0.005), and 15.5% (pϽ0.005), respectively, higher than in G1. The increases were 13.2% (pϽ0.01), 16.4% (pϽ0.01), 24.3% (pϽ0.001), and 28.4% (pϽ0.001), respectively, higher than in G2. Gamma-irradiation combined with each drug (G5) resulted in more effective recovery of SOD levels to 429.1Ϯ17.2, 441.6Ϯ22.4, 469.1Ϯ17.9, and 481.6Ϯ8.3 mg/g wet tissue, respectively. In comparison with G1, recovery increased significantly by 13.5%, 10.9%, 5.4%, and 2.9% and similarly in comparison with G2 by 31.4% (pϽ0.001) for KIN-804, 35.3% (pϽ0.001) for KIN-844, 43.7% (pϽ0.001) for KIN-806, and 47.5% (pϽ0.001) for TX-1877.
Catalase Levels As shown in Table 5 , the catalase level in EAC-bearing mice (G2) was 11.8Ϯ0.9 U/g wet tissue. This is a significant decrease of 54.8% (pϽ0.001) in comparison with the level in G1 (26.1Ϯ1.8 U/g wet tissues). Gamma-irradiation of EAC-bearing mice (G3) inhibited the EAC inoculation effect and the catalase level recovered to 16 
DISCUSSION
For successful combination of a radiosensitizer and irradiation, attention should focus on selective protection of normal tissues, the mechanism of radiosensitization, and resistance to injury inflicted by the synergistic effect of ionizing irradiation and the presence of antitumor and radiosensitizing agents. Dewys 21) reported that the presence of tumor in the human body or in experimental animals is known to affect many functions of the vital organs (i.e., liver), even when the site of the tumor does not interfere directly with organ 594 Vol. 25, No. 5 function. Recently, new 2-nitroimidazole hypoxic cell radiosensitizers have been designed to enhance sensitization by substituting their aromatic ring with the same biologically and chemically reactive groups such as hydroxamic acid and oximes that have moderate lipophilicity. [9] [10] [11] [12] Among the 2-nitroimidazoles radiosensitizers, the hydroxamic acid-type radiosensitizers KIN-804 and KIN-844 and the nitroimidazole acetoamide-type radiosensitizers KIN-806 and TX-1877 were selected and compared biochemically. These 2-nitroimidazoles have reduced neurotoxicity due to the lower lipophilicity, with enhancement ratios (ERs) of 2.00, 1.91, 1.69, and 1.75, respectively. 22) KIN-804, with a high ER and low toxicity, led to a regression of tumor size in mice treated in combination with radiation exposure.
13) KIN-844 was reported to induce slight killer and suppressor T lymphocyte infiltration but appears to have less effect than KIN-804. 23 ) KIN-806 and TX-1877 have been reported to have a biological response modifier function, such as antitumor, antimetastatic, and immunopotentiation effects, in addition to its hypoxic cell radiosensitization.
23) TX-1877 is more hydrophilic and less toxic than KIN-806 due to a hydroxyethyl group instead of a methyl group. It suppresses tumor growth remarkably and reduces lung metastasis regardless of irradiation. It also exhibited more radiosensitization and antimetastatic effects than KIN-806. 11, 12, 24) In the present study, the effects of KIN-804, KIN-844, KIN-806, and TX-1877 on AChE in the brain were examined in comparison with MISO as a positive control for neurotoxicity. The administration of MISO was found to induce a slight but significant reduction (17.5%, pϽ0.001) during the first 24 h. These results were in agreement with those reported by Brown and Lee, 25) who found a significant reduction in brain ATPases after the administration of MISO, confirming the penetration of MISO or its metabolite(s) through the blood-brain barrier. In comparison with MISO, the hypoxic cell radiosensitizers KIN-804, KIN-844, KIN-806, and TX-1877led to nonsignificant changes in AChE levels, confirming the nonneurotoxic effect on brain tissues. This experiment demonstrates that KIN-804, KIN-844, KIN-806, and TX-1877 or their metabolites do not penetrate the bloodbrain barrier, further confirming their lack of neurotoxicity.
On the other hand, EAC inoculation in Swiss albino mice has been shown to have significant deleterious effects on both free radical scavenging systems and antioxidant enzymes. GSH and G-6-PDH, and SOD and catalase are sensitive to irradiation and tumor-induced changes. 26) Significant inhibition of GSH, G-6-PDH, SOD, and catalase levels was found in EAC-bearing mice. It is postulated that GSH inhibition was due not only to oxidation of the sulfhydryl group but also to the diminished activity of glutathione reductase. Kergonou et al. 27) hypothesized that the decrease in GSH may be attributed to its conversion to the oxidized form with a minimal chance to be recycled to the reduced form again due to the inhibition of glutathione reductase. Saunders et al. 28) reported that the depletion of GSH content with or without irradiation decreased survival and led to fibroblastosis. In the present study, the decrease in GSH content either by gamma-irradiation or by tumor inoculation occurred through impaired GSH synthesis, which is associated with an increase in oxidized glutathione. This may occur due to the decreased transport activity of the oxidized GSH through membranes with a decrease in the activity of glutathione reductase which is augmented by riboflavin deficiency.
The decrease in GSH content in EAC-bearing mice administrated gamma-irradiation and/or KIN-804, KIN-844, KIN-806, and TX-1877 appears to be associated with a deficiency in G-6-PDH activity, similar to that reported by Chang et al., 29) since glutathione reductase is regarded as a regulator of the balance between NADP ϩ and NADPH in the hexose monophosphate shunt of glycolysis which serves as a hydrogen donor in the reduction of oxidized glutathione (GSSG) to GSH. In the case of G-6-PDH deficiency, red cells are unable to reduce NADP ϩ to NADPH at the normal rate which makes the system unable to reduce hydrogen peroxide or oxidized form of GSH.
14,15) Bump et al. 30) found that GSH acts in competition with electron-affinic radiosensitizers in the cell. Depletion of intra-cellular GSH might make the hypoxic cells more susceptible to radiosensitization by these electronaffinic radiosensitizers. Meister 31) reported that the cellular levels of GSH may determine the degree of drug or radiation resistance of tumors, but the capacity of tumor cells to synthesize GSH may be an important factor in this resistance. The present data revealed a pronounced improvement in GSH level in EAC-bearing mice administrated both radiation and KIN-804, KIN-844, KIN-806, and TX-1877 in comparison with the untreated EAC-bearing mice. This improvement might be due to a decrease in abnormally high uptake of antioxidants in the tumor tissues. 30) On the other hand, the free radical scavenging systems, SOD and catalase are present in all oxygen-metabolizing cells and their function is to provide a defense against the potentially damaging reactivities of superoxide and hydrogen peroxide. Our SOD and catalase assays revealed marked inhibition in liver capacity. In correlation, Sun et al. 32) reported a decrease in SOD activity in EAC-bearing mice which might be due to the loss of MnSOD activity in EAC cells and the loss of mitochondria, leading to a decrease in total SOD activity in the liver. Marklund et al. 33) suggested that SOD activity might be employed to predict radiation response. Similar to the inhibition of catalase activity, Marklund et al. 34) reported very small amounts of catalase in tumor cell lines. The inhibition of SOD and catalase activities as a result of tumor growth was observed by Sun et al., 32) and it was confirmed that lower SOD activity leads to higher radiosensitivity.
In conclusion, the hydroxamic acid-type radiosensitizers KIN-804 and KIN-844 and the nitroimidazole acetoamidetype radiosensitizers KIN-806 and TX-1877 are promising agents for the sensitization of tumor tissue to radiation effects for high localization inside the tumor and minimization of radiation effects in distant organs. TX-1877 is also a potential biological response modifier in cancer treatment.
